The applicant has conducted basic research and published extensively on the late phase allergic reaction, a response that is considered to be critical to the development of the chronic symptomatology that is present in such diseases as atopic dermatitis, allergic rhinitis, and most importantly, asthma. He has developed a rat animal model to study the pathogenesis of the late response and is now in a position to address selected important issues related to the immunologic, physiologic and biologic events critical to the development of late pulmonary allergic reactions. In addition to his independent research in this area, he has combined his knowledge of late asthmatic responses with that of his colleagues (at the University of Wisconsin), who are studying the effects of viral infections on asthma, to investigate the mechanisms by which viral upper respiratory infections predispose individuals to the development of late asthmatic responses and airway hyper-responsiveness. Thus, two important aims of this project are first (immediate goal), to identify, in ways not as readily possible in other animal models, the contribution of IgE antibody and mast cells to the events that transpire following the induction of the pulmonary allergic reaction; and second (more long term goal), to ascertain the effects that viral infections have on airway inflammation, airway mechanics, and airway responsiveness in relationship to the pulmonary allergic reaction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Academic/Teacher Award (ATA) (K07)
Project #
5K07AI000995-03
Application #
3076729
Study Section
Allergy & Clinical Immunology-1 (AITC)
Project Start
1990-09-01
Project End
1995-08-31
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Kuiken, Thijs; Taubenberger, Jeffery K (2008) Pathology of human influenza revisited. Vaccine 26 Suppl 4:D59-66
Memoli, Matthew J; Morens, David M; Taubenberger, Jeffery K (2008) Pandemic and seasonal influenza: therapeutic challenges. Drug Discov Today 13:590-5
Taubenberger, Jeffery K; Morens, David M (2008) The pathology of influenza virus infections. Annu Rev Pathol 3:499-522
Taubenberger, Jeffery K; Hultin, Johan V; Morens, David M (2007) Discovery and characterization of the 1918 pandemic influenza virus in historical context. Antivir Ther 12:581-91
Taubenberger, Jeffery K; Morens, David M; Fauci, Anthony S (2007) The next influenza pandemic: can it be predicted? JAMA 297:2025-7
Taubenberger, Jeffery K (2006) The origin and virulence of the 1918 ""Spanish"" influenza virus. Proc Am Philos Soc 150:86-112
Mehta, H; Sorkness, R; Kaplan, M R et al. (1997) Effects of dexamethasone on acute virus-induced airway dysfunction in adult rats. Pediatr Res 41:872-7
Cypcar, D; Sorkness, R; Sedgwick, J et al. (1996) Rat eosinophils: isolation and characterization of superoxide production. J Leukoc Biol 60:101-5
Sorkness, R; Lemanske Jr, R F (1996) Attenuation of airway hyperresponsiveness during acute viral infection using the 21-aminosteroid U-83836E in rats. Pulm Pharmacol 9:219-22
Gern, J E; Schroth, M K; Lemanske Jr, R F (1995) Childhood asthma. Older children and adolescents. Clin Chest Med 16:657-70

Showing the most recent 10 out of 18 publications